Mrs. Miriam Elizabeth Wagner, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Pinehaven Street Ext, Laurens, SC 29360 Phone: 864-984-6584 Fax: 864-984-6464 |
Mrs. Kenya Michelle Brown, MSR, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Pinehaven Street Ext, Laurens, SC 29360 Phone: 864-984-6584 Fax: 864-984-6464 |
Miss Lanetra Green Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 379 Pinehaven Street Ext, Laurens, SC 29360 Phone: 864-984-6584 |
Mrs. Mary Kathryn Laforge, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Pinehaven Street Ext, Laurens, SC 29360 Phone: 864-984-6584 |
Mrs. Lauren Allen Turner, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 307 Pinehaven Street, Laurens, SC 29360 Phone: 864-984-6584 |
Mrs. Heather Hawkins Franklin, MSP, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Pinehaven Street Ext, Laurens, SC 29360 Phone: 864-984-6584 |
Heather Nicholson, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Pinehaven Street Ext, Laurens, SC 29360 Phone: 864-984-6584 Fax: 864-984-6464 |
News Archive
Patient care at St. Jude doesn't stop when the child is cured. The end of successful therapy is the start of many years of follow-up care. This care is aimed at helping make the recovery process successful and preparing the family and hometown doctor for long-term complications that might arise from the disease or its treatment.
An unprecedented alliance of leading scientists, health professionals, and children's and environmental health advocates agree for the first time that today's scientific evidence supports a link between exposures to toxic chemicals in air, water, food and everyday products and children's risks for neurodevelopmental disorders.
Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2, a global, multicenter, randomized clinical trial evaluating the safety and efficacy of the Moxy™ Drug Coated Balloon for the treatment of peripheral arterial disease.
Children with autism, people with spine and brain injuries and the long-term disabled in job programs are among the 30,000 people who would lose state help under a $5.1 billion spending plan approved by a House committee Thursday.
CNS Response, Inc. reported the results of a landmark study presented by Charles DeBattista, D.M.H, M.D., at the U.S. Psychiatric and Mental Health Congress.
› Verified 7 days ago